Apollo Hospitals Secures Rs 12,540 Million Acquisition Approval from CCI

DSIJ Intelligence-1Categories: Mindshare, Trendingjoin us on whatsappfollow us on googleprefered on google

Apollo Hospitals Secures Rs 12,540 Million Acquisition Approval from CCI

The stock is down by 2 per cent in 1 year and gained 165 per cent in 5 years.

Apollo Hospitals Enterprise Limited has received formal approval from the Competition Commission of India (CCI) to proceed with its acquisition of a 30.58 per cent equity stake in its subsidiary, Apollo Health and Lifestyle Limited (AHLL). The approval, granted on January 20, 2026, follows the initial board proposal from September 2025. This regulatory clearance satisfies a primary condition for the transaction under the Competition Act, 2002.

The acquisition involves purchasing 41,650,368 equity shares from the International Finance Corporation (IFC) and IFC EAF Apollo Investment Company. The total purchase consideration for the stake is valued at Rs 12,540.68 million. With the CCI’s Section 31(1) approval now secured, the company is moving forward with the finalisation of this equity consolidation.

DSIJ’s Mid Bridge uncovers the top Mid-Cap companies poised for growth, helping investors access the market’s most dynamic opportunities. Get the Full Brochure

About the Company

Apollo Hospitals was established in 1983 by Dr Prathap C Reddy, a renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country. Apollo Hospitals has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies,
Primary Care & Diagnostic Clinics and several Retail Health models.

The company has a market cap of Rs 98,200 crore and has delivered good profit growth of 34 per cent CAGR over the last 5 years with a healthy dividend payout of 21.5 per cent. The stock is down by 2 per cent in 1 year and gained 165 per cent in 5 years.

Disclaimer: The article is for informational purposes only and not investment advice.